Key facts
- It has raised $15.7M; the latest was Grant ($60K) in Jan 2025.
- Notable investors include Google for Startups, East Ventures, ACV Capital, Cercano Management, SGInnovate — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for NalaGenetics
- ·The full record, as it builds
Funding rounds
No funding rounds for NalaGenetics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NalaGenetics
Developer of a personalized prescription platform designed to offer accurate testing, impactful outcomes and localized recommendations. The company's platform increases prescription efficacy through genetic testing and information management systems, enabling patients and decision-makers to have access to personalized information on how to interact with existing healthcare technologies.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2016
- Employees
- 62
- Website
- nalagenetics.com/
- Ownership
- Privately Held (backing)
NalaGenetics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NalaGenetics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NalaGenetics in its N-PORT filings yet. We sweep new filings monthly.